-
ICT, Lasa succeed in Favipiravir drug synthesis, to commence production
expresspharma
June 18, 2020
The collaborators aim to manufacture close to 10,000 doses of the antiviral to begin with.
-
EU calls for global alliance to buy COVID-19 vaccines up front
expresspharma
June 18, 2020
It is planning to spend around $2.3 billion on the advance purchase of vaccines in testing on behalf of the 27 EU states.
-
Gilead announces results from Phase 3 Trial of remdesivir in patients with moderate COVID-19
worldpharmanews
June 17, 2020
Gilead Sciences, Inc. announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia.
-
Promising path found for COVID-19 therapeutics
worldpharmanews
June 17, 2020
A team of researchers at the University of Georgia has successfully demonstrated that a set of drug-like small molecules can block the activity of a key SARS-CoV-2 protein - providing a promising path for new COVID-19 therapeutics.
-
Up to 45 percent of SARS-CoV-2 infections may be asymptomatic
worldpharmanews
June 17, 2020
An extraordinary percentage of people infected by the virus behind the ongoing deadly COVID-19 pandemic never show symptoms of the disease, according to the results of a Scripps Research analysis of public datasets on asymptomatic infections.
-
Super-potent human antibodies protect against COVID-19 in animal tests
worldpharmanews
June 17, 2020
A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against SARS-CoV-2, the coronavirus that causes the disease, when tested in animals and human cell cultures.
-
Celltrion's infliximab biosimilar to be tested for COVID-19
pharmatimes
June 17, 2020
Celltrion Healthcare has partnered with the University of Oxford and University Hospitals Birmingham to investigate the use of infliximab biosimilar CT-P13 as a treatment for COVID-19 symptoms.
-
MHRA suspends COVID-19 hydroxychloroquine trials
pharmatimes
June 17, 2020
As of this morning – Wednesday June 17 – the current recorded case count for COVID-19 (coronavirus) in the UK has reached 298,136 with 41,969 deaths.
-
TRV027 to be tested as COVID-19 illness treatment in clinical trial
europeanpharmaceuticalreview
June 17, 2020
A clinical trial is set to investigate whether a molecule known as TRV027 is effective at preventing lung damage and the formation of blood clots in COVID-19 patients.
-
Therapeutic Solutions Initiates 500 Volunteer COVID-19 Prevention Clinical Trial Using QuadraMune
americanpharmaceuticalreview
June 17, 2020
Therapeutics Solutions announced the initiation of a clinical trial aimed at demonstrating safety and efficacy of its immune-boosting formulation QuadraMune?.